Home / News
-
-
Agilent Technologies reported after the close of the market on Wednesday that its third quarter revenues rose 6 percent year over year, thanks largely to an 11 percent increase in revenues for its diagnostics and genomics business.2019-08-28View More
-
-
Brigham and Women's Hospital announced recently that it has opened the Preventive Genomics Clinic, an academically affiliated clinical service to provide...2019-08-28View More
-
-
Genomind and NeuroFlow recently announced an agreement that combines NeuroFlow's digital health platform with Genomind's genetic testing service with the aim of improving ...2019-08-28View More
-
-
IncellDx and Kindstar Global announced recently that they have signed master collaboration and exclusive distribution agreements for three of IncellDx's single-cell immuno-oncology and oncology diagnostic products for China.2019-08-28View More
-
-
GenMark Diagnostics reported after the close of the market on Monday a 23 percent increase in second quarter revenues, driven by strong placements of its ePlex analyzer.2019-08-28View More
-
-
SpeeDx announced recently that it has raised a total of $15 million from a US investment group.2019-08-28View More
-
-
Hope that we can have the opportunity to meet again in the hero city - Nanchang.2019-08-28View More
-
-
Roche recently reported flat half-year revenues for its Diagnostics division. At constant exchange rates, diagnostics revenues were up 2 percent, primarily due to the immunodiagnostics business as well as to overall growth in the second quarter.2019-07-31View More
-
-
Freenome announced today that it has closed a $160 million Series B financing round, which it will use to further develop its early cancer detection blood test.2019-07-31View More
-
-
Thermo Fisher Scientific, the world leader in serving science, recently announced that it will be investing more than $50m (¡ê39.8m) in its global bioproduction capabilities to...2019-07-31View More
-
-
A new public-private consortium is collaborating on a project whose chief objective is an FDA-qualified composite biomarker for diagnosing nonalcoholic steatohepatitis (NASH).2019-07-31View More
-
-
Biodesix isn¡¯t looking to just be another company with lung cancer detection tests. It wants to be the lung cancer detection company. And with its most recent acquisition, the Boulder, CO-just might achieve that goal. ..2019-07-31View More
-
-
Biological Dynamics is fighting to take its diagnostic platform to the next level. And the San Diego-based company said it recently received a grant from the Bill & Melinda Gates Foundation, to help it in its mission.2019-07-31View More
-
-
ArcherDX is bringing it up a notch through a new collaboration with Ayala Pharmaceuticals, a clinical stage precision oncology company.2019-07-31View More
-
-
At the Massachusetts institute of technology researchers have invented a sensor that can speed up the process of diagnosis of sepsis recently held in Berlin...2019-07-31View More
-
-
RNAi therapeutics firm Alnylam Pharmaceuticals and consumer genetics firm 23andMe will offer free genetic test kits to first-degree family members of 23andMe customers who have a TTR variant known to cause hereditary amyloidosis.2019-07-31View More
-
-
Illumina will bring its genomics startup incubator to the UK next year.2019-07-31View More
-
-
The Parkinson's Foundation and Fulgent Genetics announced recently that they have begun a collaboration on a new genetic testing initiative for Parkinson's disease patients.2019-07-31View More
-
-
Abbott recently said that its Diagnostics business revenues grew 2 percent year over year in the second quarter, while its total revenues were up 3 percent.2019-07-31View More
-
-
PathogenDx has entered into a strategic partnership with Nationwide Laboratory Services for fungal testing of dermatology and podiatry samples.2019-07-31View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.